BOBugra Ozer

Bugra Ozer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bugra Ozer has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Figure 3 from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    Prediction of drug sensitivity using phosphoproteomic analysis. A, Classification of cell line–drug single-agent sensitivities into four quartiles, with Q1 = most sensitive and Q4 = least sensitive. B, Feature importance of phosphoproteins based on elastic net analysis shown. Features are described previously as significant if the weight is greater than +0.1 or lesser than −0.1. C, Performance of predictions of sensitivity quartile based on phosphoproteomic changes using elastic net analysis. D, Performance of prediction of sensitivity quartile based on three clinically relevant mutations (EGFR, PIK3CA, and KRAS) using elastic net analysis.

  • Open Access

    Figure 1 from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    Experimental design. Single-drug evaluation: A library of 7 targeted anticancer drugs was used. First, GI50 concentrations were determined in a panel of 35 NSCLC cell lines with diverse genetic backgrounds (44). Second, phosphoproteomic changes of 52 selected proteins were measured after 1 hour of drug exposure of the drugs at clinically relevant concentrations adjusted for protein binding and DMSO controls were measured. The phosphoproteomic protein changes were used to train machine learning predictors of sensitivity, and validated using 100-fold cross validation with a rotating set of 15% leave out for validation and 85% for training (see Materials and Methods). The same phosphoproteomic measurements were also carried out in 16 patient samples obtained from pleural effusions producing profiles that can be fed into the predictive model to predict likely response to each drug of the individual patient samples. Two-drug combination: A novel machine learning method (environmental perturbation score) using dynamic phosphoprotein data 35 cell lines exposed to the 7 drugs was used to predict combinations. All pair wise two-drug combinations (7 individual drugs) were tested in 6 representative NSCLC cell lines and Bliss synergy was calculated for all combinations. The predicted results from the environmental perturbation score was compared with the experimentally validated results.

  • Open Access

    Figure 5 from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    Experimental and predicted combinations. A, Clustered heatmap of Bliss synergy scores was experimentally measured for six cell lines treated with 21 two-drug combinations. B, Histogram representing the EPS rankings of nodes of targets of drugs in the top 25% highest Bliss synergy scores, that is, “most synergistic” (left), or the EPS rankings of nodes of targets of drugs in the 25% lowest Bliss synergy scores, that is, “least synergistic” (right). There is a significant bias toward higher EPS rankings for the most synergistic drug targets, with a significant Mann–Whitney U test P value of 0.0038875, indicating a biased distribution of rankings. C, Simulation of the Mann–Whitney U test P values obtained from 10,000-fold random permutations of EPS ranking, demonstrating the robustness of this P value.

  • Open Access

    Figure 4 from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    Dynamic changes in phosphoproteins and EPS. Exemplar of results in a cell line HCC827. A and B, Network diagrams showing phosphoproteomic changes and drug targets with color gradient blue (−1.7) and red (+1.7). Nodes that are drug targets but where phosphorylation has not been measured are denoted in gray, that is, HSP90, PI3K, and BRAF. A, Phosphoproteomic changes related to exposure to the AKT inhibitor capivasertib. B, Phosphoproteomic changes related to exposure to the MEK inhibitor trametinib. C and D, EPS calculated for nodes that are tractable on CanSAR. C, EPS scores upon exposure to the AKT inhibition capivasertib. D, EPS scores upon exposure the MEK inhibitor trametinib.

  • Open Access

    Figure 2 from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    Acute dynamic phosphoproteomic perturbation. A, Hierarchically clustered heatmap showing 52 phosphoproteomic changes measures across all 35 cell lines exposed to all seven drugs, overlaid with quartiled drug sensitivity annotation, generated using Morpheus. Blue denotes a decreased phosphoprotein, and red denotes an increased phosphoprotein. Drug sensitivity quartiles are as illustrated and discussed in Fig. 3A. Clusters are highlighted with yellow boxes. B, Unrooted dendrogram representing clustering of phosphorylated proteins measured across entire dataset, showing that receptor tyrosine kinases cluster together. Colors represent distinct clusters of the dendrogram, as per slicing at the level annotated by the turquoise line.

  • Open Access

    Figure 6 from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    Comparison phosphoprotein changes in patient samples and cell lines. A, 3D plot showing that for the first three principal components of the phosphoproteomic data, patient samples (blue diamonds) show comparable distribution with cell line data (yellow circles), indicating that changes in phosphorylation in cell line panels could potentially reflect changes within clinical samples. B, Probability density functions of cell line and patient data, showing a strong overlap in distribution and peak values between the two sample types, despite a Welch Two Sample t test, indicating that the two groups have different means (P = 0.006804). Here, x-axis plots the value of dynamic phosphoprotein changes, and the y-axis (density) is proportional to frequency.

  • Open Access

    Data from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    We hypothesize that the study of acute protein perturbation in signal transduction by targeted anticancer drugs can predict drug sensitivity of these agents used as single agents and rational combination therapy. We assayed dynamic changes in 52 phosphoproteins caused by an acute exposure (1 hour) to clinically relevant concentrations of seven targeted anticancer drugs in 35 non–small cell lung cancer (NSCLC) cell lines and 16 samples of NSCLC cells isolated from pleural effusions. We studied drug sensitivities across 35 cell lines and synergy of combinations of all drugs in six cell lines (252 combinations). We developed orthogonal machine-learning approaches to predict drug response and rational combination therapy. Our methods predicted the most and least sensitive quartiles of drug sensitivity with an AUC of 0.79 and 0.78, respectively, whereas predictions based on mutations in three genes commonly known to predict response to the drug studied, for example, EGFR, PIK3CA, and KRAS, did not predict sensitivity (AUC of 0.5 across all quartiles). The machine-learning predictions of combinations that were compared with experimentally generated data showed a bias to the highest quartile of Bliss synergy scores (P = 0.0243). We confirmed feasibility of running such assays on 16 patient samples of freshly isolated NSCLC cells from pleural effusions. We have provided proof of concept for novel methods of using acute ex vivo exposure of cancer cells to targeted anticancer drugs to predict response as single agents or combinations. These approaches could complement current approaches using gene mutations/amplifications/rearrangements as biomarkers and demonstrate the utility of proteomics data to inform treatment selection in the clinic.

  • Open Access

    An experimentally validated approach to automated biological evidence generation in drug discovery using knowledge graphs

    by Saatviga Sudhahar, Bugra Ozer, Jiakang Chang, Wayne Chadwick, Daniel O’donovan, Aoife Campbell, Emma Tulip, Neil Thompson, Ian Roberts

    Explaining predictions for drug repositioning with biological knowledge graphs is a challenging problem. Graph completion methods using symbolic reasoning predict drug treatments and associated rules to generate evidence representing the therapeutic basis of the drug. Yet the vast amounts of generated paths that are biologically irrelevant or not mechanistically meaningful within the context of disease biology can limit utility. We use a reinforcement learning based knowledge graph completion model combined with an automatic filtering approach that produces the most relevant rules and biological paths explaining the predicted drug’s therapeutic connection to the disease. In this work we validate the approach against preclinical experimental data for Fragile X syndrome demonstrating strong correlation between automatically extracted paths and experimentally derived transcriptional changes of selected genes and pathways of drug predictions Sulindac and Ibudilast. Additionally, we show it reduces the number of generated paths in two case studies, 85% for Cystic fibrosis and 95% for Parkinson’s disease.


  • Open Access

    Deciphering Drought Response Mechanisms: Transcriptomic Insights from Drought-Tolerant and Drought-Sensitive Wheat ( Triticum aestivum L.) Cultivars

    by Birsen Cevher-Keskin, Yasemin Yıldızhan, Askim Hediye Sekmen-Cetinel, Osman Uğur Sezerman, Buğra Özer, Rümeysa Fayetörbay, Selma Onarıcı, İsmail Türkan, Mahmut Tör

    Drought stress poses a significant threat to wheat ( Triticum aestivum L.) cultivation, necessitating an in-depth understanding of the molecular mechanisms underpinning drought response in both tolerant and sensitive varieties. In this study, 12 diverse bread wheat cultivars were evaluated for their drought stress responses, with particular emphasis on the contrasting performance of cultivars Atay 85 (sensitive), Gerek 79, and Müfitbey (tolerant). Transcriptomic analysis was performed on the root and leaf tissues of the aforementioned cultivars subjected to 4-hour and 8-hour drought stress and compared with controls. Differentially expressed genes (DEGs) were categorized based on their cellular component, molecular function, and biological function. Notably, there was greater gene expression variability in leaf tissues compared to root tissues. A noticeable trend of decreased gene expression was observed for cellular processes such as protein refolding and cellular metabolic processes like photorespiration as drought stress duration increased (8 hours) in the leaf tissues of drought-tolerant and sensitive cultivars. Metabolic processes related to gene expression were predominantly activated in response to 4-hour and 8-hour drought stress. The drought-tolerant cultivars exhibited increased expression levels of genes related to protein binding, metabolic processes, and cellular functions, indicating their ability to adapt better to drought stress compared to the drought-sensitive cultivar Atay 85. We detected more than 25 differentially expressed TFs in leaf tissues under 4-hour and 8-hour drought stress, while only 4 TFs were identified in the root tissues of sensitive cultivar. In contrast, the tolerant cultivar exhibited more than 80 different TF transcripts in both leaves and roots after 4 hours of drought stress, with this number decreasing to 18 after 8 hours of drought stress. Differentially expressed genes with a focus on metal ion binding, carbohydrate degradation, ABA-related genes, and cell wall-related genes were highlighted. Ferritin ( TaFer ), TaPME42 and Extensin-like protein ( TaExLP ), Germin-like protein ( TaGLP 9-1 ), Metacaspase-5 ( TaMC5 ), Arogenate Dehydratase 5 (ADT-5) , Phosphoglycerate/ bisphosphoglycerate mutase ( TaPGM ), Serine/threonine protein phosphatase 2A ( TaPP2A ), GIGANTEA ( TaGI ), Polyadenylate-binding protein ( TaRBP45B ) exhibited differential expression by qRT-PCR in root and leaf tissues of tolerant and sensitive bread wheat cultivars. This study provides valuable insights into the complex molecular mechanisms associated with drought response in wheat, highlighting genes and pathways involved in drought tolerance. Understanding these mechanisms is essential for developing drought-tolerant wheat varieties, enhancing agricultural sustainability, and addressing the challenges posed by water scarcity.


  • Open Access

    Supplementary Table from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes

    by Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, et al.

    Supplementary Table from Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes